{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:37:28Z","timestamp":1790012248428,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neuroscience.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:42:02Z","timestamp":1616784122000},"page":"370-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Current Developments in Cell Replacement Therapy for Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"463","author":[{"given":"Xiaoqian","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2021.03.022_b0005","first-page":"561","article-title":"Dopaminergic induction of umbilical cord mesenchymal stem cells by conditioned medium of choroid plexus epithelial cells reduces apomorphine-induced rotation in Parkinsonian rats","volume":"19","author":"Aliaghaei","year":"2016","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0010","doi-asserted-by":"crossref","first-page":"109674","DOI":"10.1016\/j.pnpbp.2019.109674","article-title":"Recent advances of induced pluripotent stem cells application in neurodegenerative diseases","volume":"95","author":"Amin","year":"2019","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0020","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson\u2019s disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.stem.2017.09.014","article-title":"Human trials of stem cell-derived dopamine neurons for Parkinson's disease: dawn of a new era","volume":"21","author":"Barker","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0030","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1038\/npjparkd.2015.17","article-title":"G-Force PD: a global initiative in coordinating stem cell-based dopamine treatments for Parkinson's disease","volume":"1","author":"Barker","year":"2015","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"10.1016\/j.neuroscience.2021.03.022_b0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/75705","article-title":"Cell replacement therapies for central nervous system disorders","volume":"3","author":"Bj\u00f6rklund","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0040","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4103\/1673-5374.211201","article-title":"Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons","volume":"12","author":"Boroujeni","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0045","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1227\/00006123-199505000-00027","article-title":"Implantation of fetal tissue for the management of Parkinson\u2019s disease: a technical note","volume":"36","author":"Breeze","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.stem.2014.07.003","article-title":"The developmental potential of iPSCs is greatly influenced by reprogramming factor selection","volume":"15","author":"Buganim","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.nbd.2005.09.008","article-title":"Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia","volume":"21","author":"Carlsson","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature15515","article-title":"Hallmarks of pluripotency","volume":"525","author":"De Los Angeles","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0065","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0070","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1471-4159.2003.01931.x","article-title":"Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation","volume":"86","author":"Emgard","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0075","series-title":"Chapter 9 - Current status of clinical trials of neural transplantation in Parkinson's disease","first-page":"169","author":"Evans","year":"2012"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(12)70049-2","article-title":"Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation","volume":"11","author":"Fasano","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2016.00340","article-title":"Inhibitors of MAO-A and MAO-B in psychiatry and neurology","volume":"7","author":"Finberg","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1634\/stemcells.2005-0053","article-title":"Conversion of human umbilical cord mesenchymal stem cells in Wharton\u2019s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism","volume":"24","author":"Fu","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","article-title":"Mammalian neural stem cells","volume":"287","author":"Gage","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0105","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1586\/ern.11.74","article-title":"Cell replacement therapy for Parkinson's disease: how close are we to the clinic?","volume":"11","author":"Ganz","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0110","first-page":"51","article-title":"Mesenchymal stem cell therapy in Parkinson's disease animal models","volume":"65","author":"Gugliandolo","year":"2017","journal-title":"Curr Res Transl Med"},{"issue":"Pt 6","key":"10.1016\/j.neuroscience.2021.03.022_b0115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/brain\/122.6.1121","article-title":"Sequential bilateral transplantation in Parkinson's disease: effects of the second graft","volume":"122","author":"Hagell","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0120","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cell.2010.10.008","article-title":"Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues","volume":"143","author":"Hanna","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0125","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/sj.bjc.6603671","article-title":"Telomere and telomerase in stem cells","volume":"96","author":"Hiyama","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55782\/ane-2010-1806","article-title":"Transplantation of neural stem cells derived from human cord blood to the brain of adult and neonatal rats","volume":"70","author":"Jablonska","year":"2010","journal-title":"Acta Neurobiol Exp"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0135","doi-asserted-by":"crossref","first-page":"17986","DOI":"10.3390\/ijms140917986","article-title":"Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy","volume":"14","author":"Jin","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9140541","article-title":"Therapeutic effects of CUR-activated human umbilical cord mesenchymal stem cells on 1-methyl-4-phenylpyridine-induced Parkinson\u2019s disease cell model","volume":"2016","author":"Jinfeng","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0145","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/term.504","article-title":"Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease","volume":"7","author":"Kang","year":"2013","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3727\/096368910X546580","article-title":"Medical terminations of pregnancy: a viable source of tissue for cell replacement therapy for neurodegenerative disorders","volume":"20","author":"Kelly","year":"2011","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0160","article-title":"Use of the Brown-Roberts-Wells stereotactic frame in a developing country","volume":"10","author":"Khedr","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.pbr.2016.11.011","article-title":"Strategies for bringing stem cell-derived dopamine neurons to the clinic: A European approach (STEM-PD)","volume":"230","author":"Kirkeby","year":"2017","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0175","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1006\/exnr.1997.6577","article-title":"Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue","volume":"146","author":"Kopyov","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0180","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0185","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/0024-3205(94)00389-0","article-title":"Neural transplantation, trophic factors and Parkinson's disease","volume":"55","author":"Kupsch","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/096368979500400410","article-title":"Neural transplantation","volume":"4","author":"Lindvall","year":"1995","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0195","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson\u2019s disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0205","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(88)90950-6","article-title":"Fetal dopamine-rich mesencephalic grafts in Parkinson's disease","volume":"2","author":"Lindvall","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.410310206","article-title":"Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants","volume":"31","author":"Lindvall","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2012.03.004","article-title":"Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson's disease","volume":"246","author":"Mathieu","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0220","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ejn.14051","article-title":"Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials","volume":"49","author":"Moriarty","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0230","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/pmic.200800073","article-title":"Cell surface biomarkers of embryonic stem cells","volume":"8","author":"Nagano","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0235","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ejn.14109","article-title":"Cell-based therapy for Parkinson's disease: A journey through decades toward the light side of the Force","volume":"49","author":"Parmar","year":"2019","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/jcs.113.1.5","article-title":"Human embryonic stem cells","volume":"113","author":"Pera","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0245","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1073\/pnas.0404700101","article-title":"Derivation of midbrain dopamine neurons from human embryonic stem cells","volume":"101","author":"Perrier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuint.2018.12.012","article-title":"Potential effects and molecular mechanisms of melatonin on the dopaminergic neuronal differentiation of human amniotic fluid mesenchymal stem cells","volume":"124","author":"Phonchai","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0255","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0260","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1038\/srep02786","article-title":"Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys","volume":"3","author":"Ren","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0265","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1634\/stemcells.2006-0386","article-title":"Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease","volume":"25","author":"Rodr\u00edguez-G\u00f3mez","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cbin.10029","article-title":"Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model","volume":"37","author":"Shetty","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0275","first-page":"1","article-title":"A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy","volume":"6","author":"Shroff","year":"2017","journal-title":"Am J Stem Cells"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrn2039","article-title":"How to make a mesodiencephalic dopaminergic neuron","volume":"8","author":"Smidt","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0285","series-title":"Progress in Brain Research","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/bs.pbr.2016.11.004","article-title":"Chapter 9 - Strategies for bringing stem cell-derived dopamine neurons to the clinic: The Kyoto trial","author":"Takahashi","year":"2017"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0290","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0300","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-60761-999-4_22","article-title":"Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells","volume":"698","author":"Trzaska","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10561-015-9541-6","article-title":"Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications","volume":"17","author":"Van Pham","year":"2016","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0315","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0320","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cbf.3204","article-title":"Study of differentiated human umbilical cord\u2013derived mesenchymal stem cells transplantation on rat model of advanced parkinsonism","volume":"34","author":"Wang","year":"2016","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0325","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1634\/stemcells.2005-0330","article-title":"Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease","volume":"24","author":"Weiss","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0330","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bbmt.2010.06.004","article-title":"Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats","volume":"16","author":"Xiong","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0335","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/gt.2010.152","article-title":"VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease","volume":"18","author":"Xiong","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0340","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(97)01408-X","article-title":"Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats","volume":"786","author":"Zawada","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2021.03.022_b0345","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s11064-015-1816-6","article-title":"Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson\u2019s disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons","volume":"41","author":"Zhao","year":"2016","journal-title":"Neurochem Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222100155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222100155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:06:31Z","timestamp":1759680391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222100155X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":69,"alternative-id":["S030645222100155X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.03.022","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Developments in Cell Replacement Therapy for Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of IBRO.","name":"copyright","label":"Copyright"}]}}